These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 33220521)
81. The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease. Jimenez-Ferrer I; Bäckström F; Dueñas-Rey A; Jewett M; Boza-Serrano A; Luk KC; Deierborg T; Swanberg M Brain Behav Immun; 2021 Jan; 91():369-382. PubMed ID: 33223048 [TBL] [Abstract][Full Text] [Related]
82. Preferential microglial activation associated with pathological alpha synuclein transmission. Kim YE; Lai TT; Kim YJ; Jeon B J Clin Neurosci; 2020 Nov; 81():469-476. PubMed ID: 33222964 [TBL] [Abstract][Full Text] [Related]
84. The Critical Role of SIRT1 in Parkinson's Disease: Mechanism and Therapeutic Considerations. Li X; Feng Y; Wang XX; Truong D; Wu YC Aging Dis; 2020 Dec; 11(6):1608-1622. PubMed ID: 33269110 [TBL] [Abstract][Full Text] [Related]
85. Pharmacology and Evidence-Based Strategies for Current and Emerging Treatments for OFF Periods in Parkinson Disease. Pahwa R; Isaacson SH J Clin Psychiatry; 2020 Dec; 82(1):. PubMed ID: 33264823 [TBL] [Abstract][Full Text] [Related]
86. Rotigotine patch prescription in inpatients with Parkinson's disease: evaluating prescription accuracy, delirium and end-of-life use. Ibrahim H; Woodward Z; Pooley J; Richfield EW Age Ageing; 2021 Jun; 50(4):1397-1401. PubMed ID: 33264385 [TBL] [Abstract][Full Text] [Related]
87. Impact of disease stage and age at Parkinson's onset on patients' primary concerns: Insights for targeted management. Bhidayasiri R; Boonmongkol T; Thongchuam Y; Phumphid S; Kantachadvanich N; Panyakaew P; Jagota P; Plengsri R; Chokpatcharavate M; Phokaewvarangkul O PLoS One; 2020; 15(12):e0243051. PubMed ID: 33264321 [TBL] [Abstract][Full Text] [Related]
88. Exploring the molecular approach of COX and LOX in Alzheimer's and Parkinson's disorder. Kumar A; Behl T; Jamwal S; Kaur I; Sood A; Kumar P Mol Biol Rep; 2020 Dec; 47(12):9895-9912. PubMed ID: 33263931 [TBL] [Abstract][Full Text] [Related]
89. Effects of treadmill training on gait of elders with Parkinson's disease: a literature review. Luna NMS; Brech GC; Canonica A; Ernandes RC; Bocalini DS; Greve JMD; Alonso AC Einstein (Sao Paulo); 2020; 18():eRW5233. PubMed ID: 33263679 [TBL] [Abstract][Full Text] [Related]
90. Association between hyperthyroidism and risk of incident in Parkinson's disease. Lin SR; Chen SF; Yang YC; Hsu CY; Shen YC Endocr Connect; 2021 Jan; 10(1):13-20. PubMed ID: 33263564 [TBL] [Abstract][Full Text] [Related]
91. Subacute onset dystonia in a woman affected by Parkinson's disease following SARS-COV-2 infection. Lo Monaco MR; Bentivoglio AR; Fusco D; Calabresi P; Piano C Clin Park Relat Disord; 2021; 4():100082. PubMed ID: 33263105 [No Abstract] [Full Text] [Related]
92. The Role of Glial Mitochondria in α-Synuclein Toxicity. Jeon YM; Kwon Y; Jo M; Lee S; Kim S; Kim HJ Front Cell Dev Biol; 2020; 8():548283. PubMed ID: 33262983 [TBL] [Abstract][Full Text] [Related]
96. Identification and Evaluation of Bisquinoline Scaffold as a New Candidate for α-Synuclein-PET Imaging. Kaide S; Watanabe H; Shimizu Y; Iikuni S; Nakamoto Y; Hasegawa M; Itoh K; Ono M ACS Chem Neurosci; 2020 Dec; 11(24):4254-4261. PubMed ID: 33258582 [TBL] [Abstract][Full Text] [Related]
97. Reply: Growth differentiation factor 5 exerts neuroprotection in an α-synuclein rat model of Parkinson's disease and BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson's disease. Whone A Brain; 2021 Mar; 144(2):e16. PubMed ID: 33257974 [No Abstract] [Full Text] [Related]
98. (D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model. Chiu CC; Weng YH; Huang YZ; Chen RS; Liu YC; Yeh TH; Lu CS; Lin YW; Chen YJ; Hsu CC; Chiu CH; Wang YT; Chen WS; Liu SY; Wang HL Cell Death Dis; 2020 Nov; 11(11):1018. PubMed ID: 33257649 [TBL] [Abstract][Full Text] [Related]
99. Parkinson's disease mortality and socioeconomic status: New information from a Korean study. Teive HAG; Jimenez-Shahed J Parkinsonism Relat Disord; 2020 Nov; 80():212-213. PubMed ID: 33257206 [No Abstract] [Full Text] [Related]
100. Amorphous Ropinirole-Loaded Mucoadhesive Buccal Film: A Potential Patient-Friendly Tool to Improve Drug Pharmacokinetic Profile and Effectiveness. Di Prima G; Campisi G; De Caro V J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33255761 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]